An Open-label, Multicenter, Phase Ib/II Study of AK104, Combined Chemotherapy as First-line Therapy to Treat Locally Advanced or Metastatic Non-small Cell Lung Carcinoma
Latest Information Update: 30 Apr 2024
At a glance
- Drugs Cadonilimab (Primary) ; Carboplatin; Paclitaxel; Pemetrexed
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Akeso Biopharma
- 23 Apr 2024 Status changed from active, no longer recruiting to completed.
- 17 Oct 2022 Status changed from not yet recruiting to active, no longer recruiting.
- 04 Dec 2020 New trial record